| Title |
Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan
|
|---|---|
| Published in |
International Journal of Hematology, November 2019
|
| DOI | 10.1007/s12185-019-02757-0 |
| Pubmed ID | |
| Authors |
Kohmei Kubo, Mitsuo Hori, Kensuke Ohta, Hiroshi Handa, Kiyohiko Hatake, Morio Matsumoto, Shotaro Hagiwara, Kazuteru Ohashi, Chiaki Nakaseko, Kenshi Suzuki, Shigeki Ito, Gen Kinoshita, Suresh G. Shelat, Masafumi Miyoshi, Naoki Takezako |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 39 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 15% |
| Student > Bachelor | 4 | 10% |
| Other | 3 | 8% |
| Student > Master | 3 | 8% |
| Student > Ph. D. Student | 3 | 8% |
| Other | 5 | 13% |
| Unknown | 15 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 21% |
| Biochemistry, Genetics and Molecular Biology | 4 | 10% |
| Nursing and Health Professions | 3 | 8% |
| Unspecified | 2 | 5% |
| Business, Management and Accounting | 1 | 3% |
| Other | 4 | 10% |
| Unknown | 17 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2019.
All research outputs
#15,058,508
of 23,172,045 outputs
Outputs from International Journal of Hematology
#684
of 1,420 outputs
Outputs of similar age
#214,977
of 366,254 outputs
Outputs of similar age from International Journal of Hematology
#13
of 42 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,420 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.